Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase I...

por Shu, Ya-Jun, He, Jian-Feng, Pei, Rong-Juan, He, Peng, Huang, Zhu-Hang, Chen, Shao-Min, Ou, Zhi-Qiang, Deng, Jing-Long, Zeng, Pei-Yu, Zhou, Jian, Min, Yuan-Qin, Deng, Fei, Peng, Hua, Zhang, Zheng, Wang, Bo, Xu, Zhong-Hui, Guan, Wu-Xiang, Hu, Zhong-Yu, Zhang, Ji-Kai
Publicado 2021